CAIRE Completes MGC Acquisition
The purchase of MGC Diagnostics Holdings expands oxygen equipment maker CAIRE's position and focus on diagnostic technologies.
- By David Kopf
- Jan 05, 2023
Oxygen therapy equipment manufacturer CAIRE Inc. has acquired MGC Diagnostics Holdings, Inc., expanding CAIRE's position and focus on diagnostic technologies.
The purchase adds MGC's range of non-invasive cardiorespiratory diagnostic systems, accessories, and consumables for the detection, classification, and management of cardiorespiratory disease to CAIRE's lineup of portable and stationary oxygen therapy solutions, as well as larger onsite generation solutions.
"This acquisition provides the means of serving the patient in a more holistic way — improving their quality of care throughout their entire journey," said Earl Lawson, CAIRE President and CEO. "With MGC, we address the needs of patients early in the progression of pulmonary disease with a proven portfolio of equipment that addresses awareness and diagnostic tools for the healthcare provider and clinician.
"After diagnosis, CAIRE's oxygen therapy portfolio, which covers the entire continuum of care, can be leveraged to manage the patient's disease and ensure the best possible quality of life," he added.
"This is a win for CAIRE, but most importantly, the patient and quality respiratory care everywhere," said Earl Lawson, CAIRE President and CEO. "We also expect to leverage CAIRE's well-established global distribution and manufacturing footprint to expand patient access to this expanded set of solutions."
In addition to its St. Paul headquarters, MGC has facilities in Belgium, Germany, France, and Australia with more than two hundred employees. The company's portfolio of products is anchored by its pulmonary function testing systems, cardiopulmonary exercise systems, spirometers, flow sensors, gas analyzers, and associated consumables.
"The additional resources that CAIRE and its parent NGK SPARK PLUG CO., LTD offer will enable the MGC business to accelerate its plans for expansion and growth to better serve respiratory patients around the globe," said Todd Austin, MGC CEO. "These plans include continued strengthening of the product portfolio and improved access in current and new markets."
About the Author
David Kopf is the Publisher and Executive Editor of HME Business and DME Pharmacy magazines. Follow him on LinkedIn at linkedin.com/in/dkopf/ and on Twitter at @postacutenews.